1. Home
  2. GANX vs NHTC Comparison

GANX vs NHTC Comparison

Compare GANX & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • NHTC
  • Stock Information
  • Founded
  • GANX 2017
  • NHTC 1988
  • Country
  • GANX United States
  • NHTC Hong Kong
  • Employees
  • GANX N/A
  • NHTC N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • NHTC Diversified Commercial Services
  • Sector
  • GANX Health Care
  • NHTC Miscellaneous
  • Exchange
  • GANX Nasdaq
  • NHTC Nasdaq
  • Market Cap
  • GANX 41.9M
  • NHTC 48.8M
  • IPO Year
  • GANX 2021
  • NHTC 1995
  • Fundamental
  • Price
  • GANX $2.28
  • NHTC $4.79
  • Analyst Decision
  • GANX Strong Buy
  • NHTC
  • Analyst Count
  • GANX 5
  • NHTC 0
  • Target Price
  • GANX $7.60
  • NHTC N/A
  • AVG Volume (30 Days)
  • GANX 264.8K
  • NHTC 17.5K
  • Earning Date
  • GANX 11-14-2024
  • NHTC 02-05-2025
  • Dividend Yield
  • GANX N/A
  • NHTC 16.70%
  • EPS Growth
  • GANX N/A
  • NHTC 72.15
  • EPS
  • GANX N/A
  • NHTC 0.06
  • Revenue
  • GANX N/A
  • NHTC $43,054,000.00
  • Revenue This Year
  • GANX N/A
  • NHTC N/A
  • Revenue Next Year
  • GANX N/A
  • NHTC N/A
  • P/E Ratio
  • GANX N/A
  • NHTC $79.91
  • Revenue Growth
  • GANX N/A
  • NHTC N/A
  • 52 Week Low
  • GANX $0.89
  • NHTC $4.02
  • 52 Week High
  • GANX $5.33
  • NHTC $7.40
  • Technical
  • Relative Strength Index (RSI)
  • GANX 57.43
  • NHTC 54.01
  • Support Level
  • GANX $2.06
  • NHTC $4.56
  • Resistance Level
  • GANX $2.65
  • NHTC $4.74
  • Average True Range (ATR)
  • GANX 0.29
  • NHTC 0.21
  • MACD
  • GANX 0.01
  • NHTC 0.06
  • Stochastic Oscillator
  • GANX 66.36
  • NHTC 75.00

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.

Share on Social Networks: